SCHEMBL8485182

SCHEMBL8485182

Oc1cccc(C2CNc3ccccc32)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.41
DRD1 P21728 3/20 0.41
DRD3 P35462 1/20 0.41
GAA P10253 1/20 0.40
RET P07949 1/20 0.40
PARP1 P09874 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KIF11 P52732 2/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
ADCY6 O43306 1/20 0.36
ADCY3 O60266 1/20 0.36
ADCY9 O60503 1/20 0.36
ADCY5 O95622 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8543734 0.82 HTR2A (0.46) MEN1KMT2ASMN1; SMN2L3MBTL1HTR2A
SCHEMBL8540865 0.81 ESR2 (0.41) DRD2DRD1DRD3GAAMEN1
SCHEMBL4001774 0.81 MEN1 (0.52) DRD2DRD1MEN1KMT2AKIF11
SCHEMBL6587573 0.81 SLC6A3 (0.48) GAAMEN1KMT2AHTR2AHTR2C
Hydrochloric Acid SCHEMBL11553849 0.79 MEN1 (0.50) DRD2DRD1GAAMEN1KMT2A
SCHEMBL8537530 0.79 DRD1 (0.56) DRD2DRD1GAAMEN1KMT2A
SCHEMBL8130957 0.77 GID4 (0.53) GAAMEN1KMT2AHTR2AHTR2C
SCHEMBL21856329 0.77 HTR2C (0.48) HTR2AHTR2CHTR2B
SCHEMBL21958808 0.75 HTR2C (0.41) HTR2AHTR2CHTR2B
SCHEMBL8493961 0.74 MEN1 (0.42) DRD1GAAPARP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5936098-A Process for producing indoline compounds and intermediates for the production of the same TOKYO TANABE COMPANY LIMITED (JP) 1999-08-10 US disclosed
EP-0721949-B1 INDOLINE COMPOUND AND 5-HT 3? RECEPTOR ANTAGONIST CONTAINING THE SAME AS ACTIVE INGREDIENT TOKYO TANABE CO (JP) 1998-01-07 EP disclosed
EP-0810214-A1 PROCESS FOR PRODUCING INDOLINE COMPOUNDS AND INTERMEDIATES FOR THE PRODUCTION OF THE SAME TOKYO TANABE COMPANY LIMITED (JP) 1997-12-03 EP disclosed
US-5677326-A GASTROINTESTINAL DISORDERS TOKYO TANABE COMPANY LIMITED (JP) 1997-10-14 US disclosed
EP-0721949-A1 INDOLINE COMPOUND AND 5-HT 3? RECEPTOR ANTAGONIST CONTAINING THE SAME AS ACTIVE INGREDIENT TOKYO TANABE COMPANY LIMITED (JP) 1996-07-17 EP disclosed